Sonire Therapeutics, a Palo Alto, CA-based ultrasound-based medical therapeutics company, raised $18 million in a Series A fundraising round led by Santé Ventures with participation from Fast Track Initiative FTI, Nomura SPARX Investment Japan Growth Capital Investment Corporation, and others.
More on VC News Daily →


